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Even though aging and cellular senescence appear to be linked, the biological mechanisms interconnecting these
two processes remain to be unravelled. Therefore, microRNA (miRNA/miR) profiles were analyzed ex vivo by
means of gene array in fibroblasts isolated from young and old human donors. Expression of several miRNAs was
positively correlated with donor age. Among them, miR-23a-3p was shown to target hyaluronan synthase 2
(HAS2). HA is a polysaccharide of the extracellular matrix that critically regulates the phenotype of fibroblasts.
Indeed, both aged and senescent fibroblasts showed increased miR-23a-3p expression and secreted significantly
lower amounts of HA compared with young and non-senescent fibroblasts. Ectopic overexpression of miR-23a-3p
in non-senescent fibroblasts led to decreased HAS2-mediated HA synthesis, upregulation of senescence-
associated markers, and decreased proliferation. In addition, siRNA-mediated downregulation of HAS2 and
pharmacological inhibition of HA synthesis by 4-methylumbelliferone mimicked the effects of miR-23a-3p.
In vivo, miR-23a-3p was upregulated and HAS2 was downregulated in the skin of old mice compared with young
mice. Inhibition of HA synthesis by 4-methylumbelliferone in mice reduced dermal hydration and viscoelasticity,
thereby mimicking an aged skin phenotype. Taken together, these findings appear to link miR-23a-3p and the HA
microenvironment as effector mechanisms in both dermal aging and senescence.
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INTRODUCTION
MicroRNAs (miRNAs/miRs) are small noncoding RNAs that
are emerging as key regulators of protein expression during the
aging process. Mature miRNAs act as sequence guides that
direct Argonaute proteins to mRNA complexes, leading to
their silencing and thereby contributing to tissue homeostasis,
but even more profoundly to pathophysiological processes.
Lately, several miRNAs have been found to be participating in
the regulation of skin cell senescence in vitro. In fibroblasts
miR-152 and -181a regulate cellular senescence by remodel-
ling the collagen matrix (Mancini et al., 2012). However,
attempts to translate these findings to the in vivo aging process
have failed so far.
Cellular senescence is characterized by enlargement of the
cell and reduced proliferation rate after 20 or more population
doublings, which is often accompanied by the induction of
senescence-associated b-galactosidase (SA-b-gal) activity
(Kong et al., 2011). It has been shown that genetic suppres-
sion of senescent cells ameliorates the progeroid phenotype
of BuR1-hypomorphic mice (Baker et al., 2011), but it is still
unclear how cellular senescence is linked to normal aging
(Kong et al., 2011).
The aging process of the skin is characterized by profound
changes in the dermal compartment, especially its extracel-
lular matrix. Recently, the synthesis of high-molecular-weight
hyaluronan (HA) was found to be associated with the highly
elastic skin of the naked mole rat and with the evolvement of
longevity and tumor resistance in these rodents (Tian et al.,
2013). The aim of our study was to investigate miRNAs
implicated in dermal aging and senescence and characterize
possible interrelationships with the dermal HA matrix. HA,
an unbranched polymeric carbohydrate consisting of alter-
nating disaccharide units (D-glucuronic acid(1–3)-D-N-acetyl-
glucosamine(1–4)), is a major component of the extra-
cellular matrix. The dermis contains large amounts of HA
that is synthesized by three transmembrane HA synthase iso-
enzymes (HAS 1–3) (Stern and Maibach, 2008). HA is thought
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to crucially determine cellular phenotypes by activation of its
receptors CD44 and RHAMM, thereby regulating cellular
proliferation and migration (Toole et al., 2002). Both aging
and senescence have been associated with changes in the
HA matrix, and loss of HA has been correlated to skin aging
(Tzellos et al., 2009; Rock et al., 2011; Papakonstantinou
et al., 2012). However, little is known about the molecular
mechanisms responsible for the loss of HA during intrinsic
skin aging.
Here, miR-23a-3p is identified as a regulator of both cellular
senescence and dermal aging and evidence is provided that
miR-23a-3p directly binds to HAS2 mRNA, thereby reducing
HAS2 expression. Subsequently, inhibition of HA synthesis
and pericellular HA matrix led to both reduced proliferation
and induction of senescence markers in young fibroblasts.
Furthermore, miR-23a-3p is upregulated during skin aging
in vivo and inhibition of HA synthesis causes an aged skin
phenotype in mice.
RESULTS
miRNA profile of primary human fibroblasts is altered during
aging
To investigate miRNAs involved in dermal skin aging, fibro-
blasts from volunteers of different ages (20–67 years old,
n¼10) were isolated and investigated using Affymetrix
miRNA chip technology. The expression of several miRNAs
showed a trend toward positive or negative association with
donor age (Figure 1a). Subsequently, the upregulated miRNAs
were analyzed for their ability to target mRNAs that regulate
the synthesis of HA. In silico prediction by TargetScan 6.2
software showed that the HAS2 30 untranslated region (UTR)
includes a putative conserved target site for miR-23a-3p
(Figure 1b). To further validate the positive correlation of
miRNA-23a with age, the n-number was increased to 15
(Supplementary Table S1 online) and real-time quanti-
tative PCR for miRNA-23a-3p and HAS2 was performed
(Supplementary Figure S2 online). In addition, fibroblasts were
assorted into two groups: ‘‘young’’ o35 years of age and
‘‘old’’ X60 years of age. This grouping is based on previous
work comparing specimens from ‘‘young’’ and ‘‘old’’
(Schneider and Mitsui, 1976; Giangreco et al., 2010; Rivetti
di Val Cervo et al., 2012). It was found that miR-23a-3p is
significantly increased in fibroblasts from old donors
compared with young donors. HAS2 was regulated in an
inverse manner in both cell types (Figure 1c), thereby
strengthening the hypothesis that miR-23a-3p targets HAS2
mRNA in aging and cellular senescence.
Loss of HA matrix in fibroblasts from old donors
Pericellular HA visible as HA strands was markedly reduced
in fibroblasts from old donors compared with young
donors (Figure 2a). Furthermore, the HA concentration
in the supernatant was significantly reduced with age
(Figure 2b).
To evaluate the extent of fibroblast senescence in relation to
the age of the donor, common senescent markers were
analyzed. Fibroblasts retrieved from human donors older than
60 years of age stained partially positive for SA-b-gal, showed
reduced proliferation, increased p16INK4a mRNA expression,
and no change in p21 expression compared with fibroblasts
from donors below 35 years (Figure 2c–e).
Reduced HA matrix in replicative senescence
To analyze the HA matrix in an in vitro model of replicative
senescence, human dermal fibroblasts from juvenile donors
(normal human dermal fibroblasts) were monitored through
serial passaging. Quantitative real-time reverse-transcriptase–
PCR (qRT-PCR) analysis revealed that miR-23a-3p expres-
sion was increased and HAS2 mRNA expression decreased
in senescent compared with non-senescent fibroblasts
(Figure 3a). Furthermore, the pericellular HA network
(Figure 3b) and the HA concentration in the supernatant were
significantly reduced with senescence (Figure 3c). qRT-PCR
analysis revealed that HAS2 is the most abundant isoenzyme
(95%) in all fibroblast cell populations. Therefore, the
decrease in HAS2 mRNA expression likely explains the altered
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Figure 1. miR-23a-3p is upregulated with age and is predicted to target
hyaluronan synthase 2 (HAS2). Human dermal fibroblasts from donors of
different ages were isolated and analyzed by Affimetrix miRNA gene arrays.
(a) Heatmap of microRNAs (miRNAs) that were positively (yellow) and
negatively (blue) associated with the age of the donors (n¼10). (b) miR-23a-
3p-binding site to the HAS2 30 untranslated region (UTR) as predicted by
Targetscan 6.4. (c) Fibroblasts from human donors were assigned to two groups
according to their age (young (yhF): o35 years n¼ 8; old (ohF): X60 years,
n¼ 7). The expression of miR-23a-3p and HAS2 mRNA as detected by
quantitative real-time reverse-transcriptase–PCR. Mean±SEM; *Po0.05
versus yhF.
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pericellular HA coat and reduced amount of HA in the
supernatant of senescent and old cells.
Characterization of cellular senescence showed that senes-
cent cells 4DPD25 stained positive for SA-b-gal, and revealed
a significant induction in the mRNA expression of the
senescence markers p21 and p16INK4a and a markedly
reduced proliferation rate (Figure 3d–f).
HAS2 30UTR is a direct target of miR-23a-3p
Targetscan prediction algorithms suggest that miR-23a-3p
might target the HAS2 30UTR. Transfection of mimic miR-
23a-3p into non-senescent fibroblasts led to a reduction in
HAS2 mRNA expression by B50%. In contrast, the miR-23a-
3p inhibitor did not have an effect on HAS2 mRNA expres-
sion. This fact, however, might be explained by the low
endogenous expression of miR-23a-3p in non-senescent fibro-
blasts. In senescent fibroblasts, transfection with the miR-23a-
3p mimic reduced HAS2 mRNA to the same extent as seen in
non-senescent fibroblasts. Transfection of senescent cells,
which display high levels of endogenous miR-23a-3p, with
the miR-23a-3p inhibitor increased the HAS2 mRNA copy
number twofold (Figure 3g).
Non-senescent fibroblasts were transfected with luciferase
reporters containing the HAS2 30UTR region with the putative
miR-23a-3p binding site. After additional transfection of cells
with the miR-23a-3p mimic, luciferase activity was signifi-
cantly reduced to 42%. Luciferase activity was not decreased
when cells were transfected with luciferase constructs contain-
ing a mutated version of the HAS2 30UTR binding site and the
miR-23a-3p mimic (Figure 3h).
Induction of senescence by miR-23a-3p, siHAS2, and HAS
inhibitor 4-MU
To investigate the role of miR-23a-3p in senescence, non-
senescent fibroblasts were transfected with the miR-23a-3p
mimic and oligonucleotide control. Seven days after the
transfection, a threefold increase in SA-b-gal was detected
(Figure 4a). Furthermore, miR-23a-3p induced the mRNA
expression of p21 and p16INK4a (Figure 4b). Affinity histo-
chemistry revealed that the miR-23a-3p mimic let to a
significant loss of the pericellular HA coat and HA in the
supernatant of the cells (Figure 4c and d). This was
accompanied by a significantly reduced proliferation
rate. Simultaneous overexpression of HAS2 and the
miR23a-3p mimic restored HA levels and partially inhi-
bited miR23a-3p induced cellular senescence. p21 and
p16INK4a, as well as the proliferation rate, remained at control
levels.
The role of HA in the process of senescence was further
assessed by silencing of HAS2 by siRNA. Seven days after
transfection, SA-b-gal activity, as well as mRNA expression of
p21 and p16INK4a, was significantly increased (Figure 4f
and g). Non-senescent fibroblasts treated with HAS2 siRNA
lost their pericellular HA structure and showed significant
reduction of HA in the supernatant. Reduction of HAS2
further led to reduced proliferation (Figure 4h–j). The same
effects were caused by the general HAS inhibitor 4-MU
(Supplementary Figure S1 online). Importantly, inhibition of
mir-23a-3p in senescent fibroblasts reduced the senescent
phenotype of the cells and rescued the loss of the HA matrix
(Figure 5a–e).
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Figure 2. Reduced hyaluronan (HA) matrix in fibroblasts derived from donors of old age and association with senescence. Fibroblasts from human donors were
assigned to two groups according to their age (young (yhF): o35 years n¼ 8; old (ohF): X60 years, n¼7). (a) Staining of the pericellular HA coat (HA¼ green,
Zeiss observer, 63, bar¼ 50mm). (b) The HA concentration measured by HA-binding protein–based ELSA. (c) Senescence-associated (SA)-b-galactosidase
staining (arrows indicate SA-b-galactosidase-positive cells, Zeiss observer,  40, bar¼50mm) and cell count of SA-b-galactosidase-positive cells. (d) mRNA
expression of senescence markers p21 and p16INK1a. (e) The increase in senescence markers was accompanied by a reduced proliferation rate of ohF as detected
by carboxyfluorescein succinimidyl ester staining and FACS analysis. n¼ 5–7, mean±SEM; *Po0.05 versus yhF.
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Inhibition of HA synthesis causes an aged phenotype of the skin
In skin biopsies from mice aged 18 and 48 weeks, the miR-
23a-3p copy number was increased and the HAS2 mRNA
expression decreased (Figure 6a), as seen in aged and
senescent human dermal fibroblasts previously.
To test in vivo whether reduced HA synthesis indeed causes
aging of the skin, skh-1 hairless mice received the HAS
inhibitor 4-MU starting at 8 weeks of age. Moisture and
viscoelasticity of the skin were measured initially and after 10
and 40 weeks of treatment. After 10 weeks, the moisture of the
skin was significantly reduced by 4-MU compared with that of
control animals.
The moisture in intrinsically aged control mice took 40
weeks to drop to a level similar to that of 4-MU-treated mice
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Figure 3. Loss of hyaluronan (HA) in senescent fibroblasts is mediated by miR-23a-3p targeting the 30 untranslated region (UTR) of hyaluronan synthase 2
(HAS2). Normal human dermal fibroblasts (NHDF, n¼ 5) were driven into replicative senescence (sen, n¼6). (a) miRNA-23a-3p and HAS2 mRNA expression.
(b) Staining of the pericellular HA coat (HA¼ green, Zeiss observer,  63, bar¼50mm). (c) HA concentration in the supernatant. (d) Senescence-associated
(SA)-b-galactosidase staining (arrows indicate SA-b-galactosidase-positive cells, Zeiss observer,  40, bar¼50mm) and cell count of SA-b-galactosidase-
positive cells. (e) mRNA expression of p21 and p16INK1a. (f) Proliferation rate of NHDF (sen). (g) HAS2 mRNA expression after transfection of NHDF (n¼3)
and NHDF (sen) (n¼ 3) with miR-23a-3p mimic and inhibitor. (h) Luciferase activity after transfection of NHDF with vector containing the HAS2 30UTR (HAS2
UTR) or a mutant form of the HAS2 30UTR (HAS2 mutant) in the presence and absence of miR-23a-3p (all n¼ 3). Mean±SEM; *Po0.05 versus control.
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at week 10 (Figure 6c–e). The same trend was observed for
viscoelasticity. The loss of moisture and viscoelasticity corre-
lated to loss of HA, because control mice at the age of 40
weeks showed approximately the same low level of HA as
mice treated with 4-MU for 10 weeks. Close-up photographs
taken with a UVA camera revealed smooth skin in 18-week-
old control mice, but wrinkling in mice treated with 4-MU.
The skin wrinkling of 4-MU-treated mice was similar to that of
intrinsically aged mice at 48 weeks (Figure 6e). Together, the
data suggest that loss of HA leads to a rapid acceleration of
skin aging in mice.
DISCUSSION
The deterioration of the dermis upon aging is thought to be
partially determined by structural and functional changes of
the extracellular matrix. HA is synthesized by dermal fibro-
blasts and represents a quantitative and functionally impor-
tant component of the extracellular matrix. Whereas acute
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Figure 4. Influence of miR-23a-3p and hyaluronan synthase 2 (HAS2) on cellular senescence. Normal human dermal fibroblasts were transfected with
(a–e) the miR-23a-3p mimic (23a-3p mim., n¼ 3), the HAS2 expression vector (HAS2 oe, n¼3), both (n¼ 3), or (f-k) with siHAS2 (n¼3). After 7 days, cells
were stained for (a, f) senescence-associated (SA)-b-galactosidase (arrows indicate SA-b-galactosidase-positive cells, Zeiss observer, 40, bar¼ 50mm) and
positive cells were counted. (b, g) mRNA expression of p21 and p16INK1a was determined by quantitative real-time reverse-transcriptase–PCR. (c, h) The HA
matrix was analyzed by affinity histochemical staining of HA (HA¼ green, Zeiss observer,  63, bar¼50mm), and (d, i) the amount of HA secreted into the
supernatant of the cells was quantified. (e, j) The miR-23a-3p mimic led to a reduction in the proliferation rate as determined by carboxyfluorescein succinimidyl
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erythema leads to upregulation of HA synthesis (Averbeck
et al., 2007), dermal HA content decreases during chronic
aging (Breen et al., 1970; Dai et al., 2007), suggesting a
functional role of HA in the reduced regenerative potential
and aged phenotype of dermal fibroblasts. However, the
mechanisms for this loss during intrinsic aging are still
unknown. Apart from degradation by hyaluronidases
(Malaisse et al., 2014) and other known transcriptional regu-
lators, HAS mRNA may be targeted by miRNAs. Here, we
demonstrate that age-related changes in miRNA expression in
human dermal fibroblasts modify the HA matrix and that there
is concordance in the expression profiles during aging in vivo
and replicative senescence in vitro.
Global miRNA analysis has been performed in different
species and tissue types (Drummond et al., 2008; Bates et al.,
2010) and miRNAs have been demonstrated to affect
pathways involved in aging (Jia et al., 2004; Elia et al.,
2009). Here we identified several miRNAs that are regulated
during dermal aging. Of these miRNAs, miR28-3p has been
shown to induce senescence in murine embryonic fibroblasts
by downregulation of ASF/SF2 (Verduci et al., 2010) and
might therefore be involved in aging processes. In contrast,
miR-181a was downregulated in aged fibroblasts ex vivo,
although it induces cellular senescence in fibroblasts (Mancini
et al., 2012) in vitro. Other miRNAs that have previously been
associated with senescence and aging were not regulated in
this study—e.g. miR-21 (Dellago et al., 2013) and miR-34 (Liu
et al., 2012)—possibly because of organ- and species-specific
effects. miR23a, which is increased in senescent endothelium
(Dellago et al., 2013), was the only age-correlated miRNA in
our study that was predicted to directly target HA synthesis.
Furthermore, miR409-5p was predicted (TargetScan software)
to target HA and proteoglycan link protein 4 mRNA and
miR181a to target both aggrecan and HA and proteoglycan
link protein 1 mRNA. The possibility that other age-associated
miRNAs affect additional mRNAs related to the structure and
function of the HA matrix further corroborates the hypothesis
that the HA matrix has a role in aging and senescence.
There is experimental evidence that aging involves telomere
shortening, accumulation of p16INK1a, and the p53 pathway,
but their role in aging has been debated (Janzen et al., 2006;
Dumble et al., 2007). The question whether replicative
senescence is involved in aging remains to be resolved; how-
ever, cells with a senescent phenotype have been reported to
accumulate with increasing age in mice and humans (Herbig
et al., 2006). Here, comparison of fibroblasts from donors
below 35 years of age and above 60 years of age revealed a
significant increase in the number of SA-b-gal-positive cells.
However, compared with fibroblasts driven into senescence
by population doubling, the effect was small. This is in
agreement with experimental data showing that senescent
fibroblasts cannot be found in aged tissue per se; however, an
inverse relationship has been suggested between donor age
and the replicative life span in vitro (Schneider and Mitsui,
1976; Stenderup et al., 2003). It needs to be kept in mind that
chronological aging and biological aging do not necessarily
progress at the same rate. Thus, chronological age gives only a
rough estimate for the age association.
Senescence can be controlled by both the p21 and the
p16INK1a pathway (Jenkins, 2002). Whereas p16 INK1a and p21
were increased in senescent cells, intrinsically aged cells from
old donors in our hands only revealed an induction of
p16 INK1a but no change in p21 mRNA expression, possibly
explaining the less pronounced senescent phenotype (Figures
2 and 3). Studies evaluating the effect of miRNAs on
senescence to date have focused on the p16 and p21 path-
ways (Maes et al., 2009; Hackl et al., 2010) and did not
translate these finding into the in vivo aging process. Even
though regulation of cell cycle progression pathways has not
been proven to be consistently correlated in aged and
senescent cells, it is of interest that commonly an association
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Figure 5. Inhibition of mir23a-3p represses senescence and induces
hyaluronan (HA) synthesis in senescent fibroblasts. Senescent normal human
dermal fibroblasts (NHDFs) were transfected with the miR-23a-3p inhibitor
(all n¼ 3). After 7 days, cells were stained for (a) senescence-associated
(SA)-b-galactosidase (arrows indicate SA-b-galactosidase-positive cells, Zeiss
observer,  40, bar¼50mm), and positive cells were counted. (b) mRNA
expression of p21 and p16INK1a was determined by quantitative real-time
reverse-transcriptase–PCR. (c) The HA matrix was analyzed by affinity
histochemical staining of HA (HA¼ green, Zeiss observer,  63, bar¼50mm)
and (d) the amount of HA secreted into the supernatant of the cells was
quantified. (e) miR-23a-3p inhibitor led to an induction of the proliferation
rate as determined by carboxyfluorescein succinimidyl ester staining and
FACS analysis. Mean±SEM; *Po0.05 versus control.
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between age-repressed gene expression and replicative
senescence is found (Wagner et al., 2009).
In addition to chronological/biological aging, miR-23a-3p
expression correlated with senescence. A causal relationship
was established by transfection of cells with a miR-23a-3p
mimic, which increased the expression of senescent markers,
reduced cellular proliferation, and led to loss of HAS2 mRNA
expression and the pericellular and extracellular HA. As miR-
23a-3p overexpression led to the degradation and remodeling of
the HA matrix, we hypothesized that miR-23a-3p supports
senescence via its effects on HAS2, which is the predominant
HAS isoenzyme in fibroblasts. This hypothesis was further
strengthened by the observation that simultaneous overexpres-
sion of miR23a-3p and HAS2 restored the HA matrix and the
cellular phenotype. In embryonic fibroblasts, disintegration of
the HA network structure by modulation of the HA binding
protein versican led to premature senescence (Suwan et al.,
2009). Even though effects mediated by reduction of HAS2 and
HA were distinct, the effects of miR-23a-3p upregulation were
even more pronounced. In addition, overexpression of HAS2
could not completely antagonize the induction of cellular sene-
scence by miR23a-3p, likely because it regulates other targets as
well. miR-23a-3p has been predicted to target ZNF138,
ZNF714, UBA6, and many others. In particular, zinc finger pro-
teins (ZNF) have been proposed to have a role in aging, thereby
making secondary mechanisms to the HAS2/HA loop likely.
Apart from its effect on cellular senescence, the present study
revealed that the same regulation pattern—miR-23a-3p upre-
gulation and HAS2 downregulation—occurs in the skin of aged
mice (Figure 6). To further establish the role of HA in intrinsic
aging, mice were treated with the HAS inhibitor
4-MU, which led to an aged skin phenotype. In fibroblasts it
has been demonstrated that transforming growth factor-b-
mediated HA-CD44/EGF-R signaling is essential for fibroblast
functionality, and decrease of either component has been
associated with aging (Dai et al., 2007; Simpson et al., 2010;
Rock et al., 2011). The mechanism behind the induction of
aging and senescence through loss of HA, however, remains to
be elucidated. The phosphatidylinositol 30-kinase/Akt pathway
has recently been shown to suppress senescence and to
stimulate proliferation (Engelman et al., 2006; Conte et al.,
2011; Kennedy et al., 2011). Furthermore, HA signaling
activates this pathway (Toole, 2004). It may therefore be
speculated that activation of phosphatidylinositol 30-kinase/
Akt signaling by HAS2-dependent HA retards fibroblast
senescence. In line with this hypothesis, we have found
reduced Akt phosphorylation in fibroblasts treated with siRNA
HAS2 or the miR23a mimic (Supplementary Figure S3 online).
A limitation of the present study is the lack of data proving
the causal interrelationship of miR23a-3p, HAS2, and skin
aging or senescence in vivo. This could only be achieved by an
in vivo rescue experiment using a mouse model of HAS2
overexpression in the skin, which may show resistance to skin
aging. However, this is beyond the scope of this study. So far,
the closest experiments in nature are those conducted on the
naked mole rat (Tian et al., 2013) and Shar-Pei Dogs, which
have naturally occuring HAS2 mutations and overexpression,
respectively, that are associated with strong skin phenotypes.
In conclusion, we show that miR-23a-3p induces cellular
senescence by downregulating HAS2 expression and HA
synthesis in vitro. Of note, the inhibition of HAS2/HA synthesis
by miR-23a-3p might represent a common mechanism of both
aging and senescence. As intrinsic aging is an unpreventable
complex biological process that affects all internal organs, the
present finding might also be relevant in other organ systems—
e.g. the heart—and may be considered an important target for
pharmacological intervention in age-related diseases.
METHODS
Cell culture
Dermal fibroblasts from female volunteers (as detailed in
Supplementary Methods online) were prepared as described pre-
viously (Tigges et al., 2013) and used at passages 2–5. Patients were
informed beforehand and gave written informed consent. The
preparation of primary human fibroblasts was fully approved by
the Ethics Committee, Heinrich-Heine-University of Du¨sseldorf
(Project-No TOX_EF_D01/2008). This study was conducted in com-
pliance with the Declaration of Helsinki Principles.
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Figure 6. Hyaluronan synthase 2 (HAS2) mRNA and miR-23a-3p expression in young and old mice and hyaluronan (HA) reduction induces dermal aging.
Skin biopsy samples were taken from Skh-1 hairless mice at the age of 18 weeks (young n¼ 6) and 48 weeks (old n¼10). (a) Expression of miR-23a-3p (23a-3p)
and HAS2 mRNA as detected by quantitative real-time reverse-transcriptase–PCR. (b–e) Skh-1 hairless mice were treated with the HA synthase inhibitor
4-MU (n¼ 7 over a course of 40 weeks), and skin parameters were measured using the Cortex technology system. (b) Moisture, (c) viscoelasticity (Ve),
(d) HA content of the skin, and (e) UVA picture of representative skin areas at the back of the animals (bar¼0.5cm). Mean±SEM; *Po0.05 versus
untreated/young mice.
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Population-doubling (PD) analysis was performed as described
previously (Li et al., 2013). Cells were declared senescent when they
reached DPD425, were SA-b-gal positive, and had increased p21
and p16INK4a mRNA expression.
Immunoblotting
Immunoblotting was performed using standard protocols. The anti-
bodies used were anti-Akt (Cell Signaling no. 9272S, Leiden, The
Netherlands), anti-pAkt (Cell Signaling no. 9271S), and b-tubulin
(Sigma Aldrich, Munich, Germany) and were detected using infrared-
fluorescent coupled secondary antibodies allowing fluorescent detec-
tion on a LI-COR Odyssey Infrared Imaging System (Bad Homburg,
Germany).
Evaluation of SA-b-gal and measurement of cellular proliferation
were performed using standard methods as outlined in the
Supplementary Methods online.
Microarray-based miRNA expression profiling
RNA fibroblast cultures were extracted with the miRNeasy kit
(Qiagen, Hilden, Germany). One microgram of total RNA was
labeled using the Flash Tag Biotin HSR labeling kit (Genisphere,
Hatfield, PA) and hybridized on Affymetrix GeneChip miRNA arrays
(Affymetrix, Santa Clara, CA) according to the manufacturers’ proto-
cols. The relevant microarray data have also been deposited in
NCBI’s Gene Expression Omnibus, and are accessible through Gene
Expression Omnibus Series accession number GSE55299. Data
analysis was performed as outlined in Supplementary Methods
online.
Bioinformatics
Analysis of miRNA target sites was performed using the TargetScan
6.2 software (http://www.targetscan.org/cgi-in/targetscan/vert_61/
view_gene.cgi?taxid=9606&rs=NM_005328).
Affinity histochemistry
Fibroblasts were fixed in acetic acid (5%v/v)–formalin (3.7%v/v)–
ethanol (70%v/v) and stained with HA-binding protein (Seikagaku,
Tokyo, Japan) followed by Streptavidin–FITC (Dako, Carpinteria, CA)
as described previously (Evanko et al., 1999).
Determination of the HA concentration in fibroblast cell culture
supernatants
An HA-binding protein–based commercial kit (Corgenix, Broomfield,
CA) was used according to the manufacturer’s instructions. The
quantity of HA was normalized to the total amount of protein of
the cell layer (Rock et al., 2011).
Real-time RT-PCR
HAS2 and GAPDH mRNA expression was determined as described
previously with the SYBR Green PCR Master Mix (Applied Biosys-
tems, Carlsbad, CA) (Rock et al., 2011). The 2(DDC(t)) method was
used to calculate relative expression levels.
Mice
Biopsy samples from young (8 weeks) and aged (1.5 years) C57BL6
mice were taken from the back of the animals. SKH-1 hairless mice
were treated with 4-MU-containing chow at a daily dose of 250 mg
per mouse starting at the age of 8 weeks as described (Nagy et al.,
2010). Biopsy samples from the back of the 4-MU-treated and control
animals were taken at the ages of 8, 18, 28, 38, and 48 weeks.
The animal experiments were approved by the local animal
experimentation ethics committee.
miRNA qPCR (Applied Biosystems), transfection with siRNA,
miRNA Mimic and Inhibitor with RNAiMAX Reagent (Invitrogen,
Karlsruhe, Germany), transfection with HAS2 expression vector using
Effectene (Qiagen), Luciferase assay (Promega, Mannheim, Germany),
and design of the skin parameter constructs (Cortex Technology,
Hadsund, Denmark; Khazaka Electronic, Ko¨ln, Germany) were
carried out following the respective manufacturer’s protocols as
outlined in the Supplementary Methods online.
Statistics
For the miRNA array data, the Pearson‘s correlation coefficient
between the expression of each miRNA and the respective age over
all samples was‘‘ calculated. By calculating the Fisher’s Z-transforma-
tion of the correlation coefficients, we assigned a P-value of age
association to each miRNA. A miRNA was determined to be
significantly associated with age if its P-value of age association
was o0.1. The correlation in Figure 1c was analyzed by nonpara-
metric Spearman’s correlation. All other data sets were analyzed by
either ANOVA and the Bonferroni post hoc test or by Student’s t test
as appropriate.
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